A similar situation is described for TPI, its increase in gastric cancers (GC) is linked to a negative prognostic for survival in GC patients [46], while in hepatocellular carcinoma an increased TPI acts as a tumor suppressor [47]. This evidence concerns the gene TPI1 and gastric cancer.